ERCP market developments and opportunities (2026–2030)
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Expected To Scale Between 2026 And 2030?
The endoscopic retrograde cholangiopancreatography (ercp) market size has experienced robust growth in recent years. It is forecast to increase from $1.86 billion in 2025 to $2.03 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.6%. This historical growth can be ascribed to factors like gallstone prevalence, an aging population, the gastrointestinal disease burden, the expansion of hospital endoscopy, and imaging-guided procedures.
The market for endoscopic retrograde cholangiopancreatography (ercp) is projected to experience substantial expansion over the coming years, anticipated to reach a valuation of $2.79 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.3%. This expansion during the projection period is primarily driven by factors such as advanced endoscopic training, the early detection of pancreatic conditions, an increase in therapeutic procedures, enhancements in hospital infrastructure, and the rising demand for minimally invasive care. Key developments expected within this period encompass a growing prevalence of biliary disorders, a greater adoption of therapeutic endoscopy, an increase in minimally invasive GI procedures, the establishment of more advanced endoscopy units, and an emphasis on the early diagnosis of pancreatic diseases.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Key Drivers Are Affecting The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Development?
The growing occurrence of digestive system ailments is projected to boost the expansion of the endoscopic retrograde cholangiopancreatography (ERCP) market in the future. These conditions encompass various illnesses or diseases impacting the entire gastrointestinal (GI) tract, from the mouth, esophagus, and stomach to the small intestine, large intestine (colon), rectum, and anus, along with supportive organs such as the liver, gallbladder, and pancreas. The heightened incidence of gastrointestinal conditions stems from multiple factors, including shifts in diet, an older demographic, antibiotic consumption, lifestyle choices, and environmental elements. ERCP aids in managing patients suffering from gastrointestinal issues by offering a less intrusive approach to identify and resolve problems within the bile and pancreatic ducts, for example, gallstones, constrictions, growths, or infections. As an illustration, figures from January 2024 by the American Cancer Society, a US-based non-profit organization, predict approximately 26,890 new cases of stomach cancer in the United States, with an estimated 10,880 fatalities from this cancer type. Consequently, the rising occurrence of gastrointestinal conditions is propelling the market expansion for endoscopic retrograde cholangiopancreatography (ERCP).
How Is Segmentation Applied In The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Segment Analysis?
The endoscopic retrograde cholangiopancreatography (ercp) market covered in this report is segmented –
1) By Product: Endoscopes, Endotherapy Devices, Visualization Systems, Energy Devices
2) By Application: Biliary Sphincterotomy, Biliary Dilatation, Biliary Stenting, Pancreatic Sphincterotomy, Pancreatic Duct Dilatation, Pancreatic Duct Stentin
3) By End User: Hospitals And Clinics, Ambulatory Surgery Centers, Other End Users
Subsegments:
1) By Endoscopes: Flexible Endoscopes, Semi-Rigid Endoscopes, High-Resolution Endoscopes
2) By Endotherapy Devices: Stone Extraction Devices, Balloon Dilatation Catheters, Stents, Biopsy Forceps
3) By Visualization Systems: High-Definition Visualization Systems, Endoscopic Imaging Systems, Video Endoscopes
4) By Energy Devices: Electrosurgical Devices, Laser Devices, Argon Plasma Coagulation Systems
What Trends Are Transforming The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market?
Major companies operating in the ERCP market are actively developing innovative technologies, such as the cholangioscope direct visualisation system, to offer advanced, high-resolution direct viewing of the bile and pancreatic ducts. This medical device provides advanced, high-resolution imaging of these ducts during ERCP procedures. For instance, in July 2024, Penlon Limited, a UK-based medical device company, introduced the VedVision Cholangioscope Direct Visualisation System. This advanced medical device is specifically designed for high-resolution, direct visualization of the bile and pancreatic ducts, thereby enhancing diagnosis and therapeutic intervention during ERCP procedures. It is equipped with a 2 mm accessory channel and a dedicated guidewire channel for secure access, supported by a full range of accessories such as biopsy forceps, stone extraction baskets, cytology brushes, and polypectomy snares.
Who Are The Companies Participating In The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Environment?
Major companies operating in the endoscopic retrograde cholangiopancreatography (ercp) market are Medtronic plc, Fujifilm Holdings Corporation, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Ottomed Endoscopy, W. L. Gore & Associates Inc., Streis plc, Cook Group, KARL STORZ SE & Co. KG, CONMED Corporation, PENTAX Medical Inc., AMBU Inc., Samsung Medison Co. Ltd., Medi-Globe GmbH, Telemed System Inc., Micro-Tech Endoscopy Inc., Hobbs Medical Inc., Shaili Endoscopy Pvt. Ltd.
Get The Full Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Report:
Where Is The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Most Concentrated Geographically?
North America was the largest region in the endoscopic retrograde cholangiopancreatography (ERCP) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endoscopic retrograde cholangiopancreatography (ercp) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market 2026, By The Business Research Company
Capsule Endoscopy System Market Report 2026
https://www.thebusinessresearchcompany.com/report/capsule-endoscopy-system-global-market-report
Endoscopic Ultrasound Market Report 2026
https://www.thebusinessresearchcompany.com/report/endoscopic-ultrasound-global-market-report
Primary Biliary Cholangitis Market Report 2026
https://www.thebusinessresearchcompany.com/report/primary-biliary-cholangitis-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
